43 results on '"Egeler, Maarten"'
Search Results
2. Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?
3. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
4. The yield of monitoring for HSV and VZV viremia in pediatric hematopoietic stem cell transplant patients
5. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning
6. Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation
7. Severe lung injury and lung biopsy in children post-hematopoietic stem cell transplantation: The differences between allogeneic and autologous transplantation
8. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years
9. Phage display generation of a novel human anti-CD1A monoclonal antibody with potent cytolytic activity
10. The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer
11. Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: Is it effective?
12. Pro-inflammatory chemokine–chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
13. Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: Differential roles for CCR2, CCR5, CXCR4 and CXCR7†
14. Psychometric qualities of the Dutch version of the Pediatric Inventory for Parents (PIP): a multi-center study
15. Prognostic factors in pulmonary metastasized high-grade osteosarcoma
16. 2′-chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the histiocyte society
17. Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosis
18. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
19. Health-related quality of life, cognitive functioning and behaviour problems in children with Langerhans cell histiocytosis
20. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
21. Analysis of Outcome for Patients With Mass Lesions of the Central Nervous System Due to Langerhans Cell Histiocytosis Treated With 2-Chlorodeoxyadenosine
22. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis
23. Health-Related Quality of Life and Coping Strategies of Children After Treatment of a Malignant Bone Tumor: A 5-Year Follow-Up Study
24. THE IMMUNOLOGICAL BASIS OF LCH: A BIOLOGICAL UPDATE: SL.067
25. The Histiocyte Society 20th Annual Meeting
26. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
27. More on Pamidronate in Langerhans'-Cell Histiocytosis
28. Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis
29. Bisphosphonate therapy in Langerhans cell histiocytosis: an international retrospective descriptive study
30. Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?
31. Bisphosphonate Therapy in Langerhans Cell Histiocytosis: An International Retrospective Descriptive Study
32. The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer
33. THE QLIC-ON STUDY: MONITORING HEALTH RELATED QUALITY OF LIFE IN CHILDHOOD ONCOLOGY - PROVIDING PATIENT REPORTED OUTCOMES TO PEDIATRIC ONCOLOGISTS IN CLINICAL PRACTICE
34. Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.
35. Differences in Telomerase Expression by the CD1a+ Cells in Langerhans Cell Histiocytosis Reflects the Diverse Clinical Presentation of the Disease
36. Cyclosporin A Kinetics in Children after Stem Cell Transplantation.
37. Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.
38. Need for a cooperative study: Pulmonary langerhans cell histiocytosis and its management in adults
39. Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Children with Recurrent or Poor Risk Solid Tumors † 755
40. Pediatric Allogeneic Bone Marrow and Stem Cell Transplantation in Alberta, Canada † 754
41. Epidemiologic study of Langerhans cell histiocytosis in children
42. Immunosuppression: Preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistiocytosis (FHL)
43. Optic nerve relapse in a child with common acute lymphoblastic leukemia, treated with systemic anti-CD-20 (rituximab).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.